AASLD Conference: New Therapeutic Strategies
for Hepatitis C
June
15-16,
2001
Chicago
Report
3
Both
The Virus and The Person's Immune System Affect Hepatitis C Clearance and
Response To Interferon Therapy
New Drugs In Development
IL-10 and IL-12
Study Results
Strong CTL Response
May Be Needed
Hyperimmune C Immunoglobulin
Long Term Maintenance
Therapy For HCV: IFN/RBV non-responders are responding to pegylated interferon;
ribavirin monotherapy, phlebotomy and pentoxyfilline suggested as maintenance
therapy
Previous Non-Responders Can Respond To Pegylated Interferon
Report
2
Estrogen
Replacement Therapy Enhances The Response Rate to Interferon Of HCV+ Post
Menopausal Women
Report
1
Hepatitis C Genetic
Diversity and High Level of Viral Replication Pose a Challenge
New Drugs In Development